GlassScriptPhysician profile
Katharine M Cronk
NPI 1669652715
$2,261.58
in general payments reported to CMS, 2019-2025
14 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $25.06 · 2021: $155 · 2022: $170 · 2023: $163 · 2024: $1,144 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,097 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,097.05 |
| Food and Beverage | $649.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $1,097.05 | 2024 | Baguera-C |
| Boston Scientific Corporation | $374.13 | 2021-2025 | Coveredge 32, Wavewriter Alpha Prime 16, Artisan |
| Relievant Medsystems, INC. | $196.27 | 2022-2023 | Intracept |
| Mml US, INC. | $176.58 | 2025 | Reactiv8 |
| Medtronic, INC. | $120.19 | 2023 | Osteocool Rf Ablation System |
| Stryker Corporation | $83.37 | 2019-2022 | |
| Csl Behring | $45.90 | 2019 | |
| Orthofix Medical, INC. | $37.25 | 2021-2024 | Cervical-Stim |
| Solventum Corporation | $36.04 | 2025 | Prevena |
| Spineart USA INC | $25.06 | 2020 | |
| Sunovion Pharmaceuticals INC. | $23.26 | 2019 | |
| Baxter Healthcare | $17.86 | 2025 | Floseal |
| Spine Wave, INC. | $15.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katharine Cronk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.